Arrail Group Limited (HKG:6639)
Hong Kong · Delayed Price · Currency is HKD 2.600
-0.110 (-4.06%)
Aug 1, 2025, 4:08 PM HKT
Ligand Pharmaceuticals Market Cap
Arrail Group has a market cap or net worth of 1.46 billion as of August 1, 2025. Its market cap has decreased by -19.90% in one year.
Market Cap
1.46B
Enterprise Value
1.47B
Revenue
1.81B
Ranking
n/a
PE Ratio
49.41
Stock Price
$2.60
Market Cap Chart
Since March 22, 2022, Arrail Group's market cap has decreased from 8.03B to 1.46B, a decrease of -81.79%. That is a compound annual growth rate of -39.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.46B | 17.39% |
| Dec 31, 2024 | 1.24B | -62.35% |
| Dec 29, 2023 | 3.31B | -42.46% |
| Dec 30, 2022 | 5.75B | -28.41% |
| Mar 22, 2022 | 8.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 278.50B |
| Hansoh Pharmaceutical Group Company | 207.51B |
| Innovent Biologics | 158.98B |
| JD Health International | 156.01B |
| Akeso | 140.29B |
| Sino Biopharmaceutical | 130.92B |
| WuXi Biologics | 127.57B |
| CSPC Pharmaceutical Group | 113.07B |